A precision-engineered dendritic cell-targeted mRNA nanovaccine for enhanced antiviral immunity
Shugang Qin(Sichuan University), Xiangrong Song(Sichuan University), Zhongshan He(University of Virginia), Chunli Yang(Sichuan University), Xinyang Jin(Macau University of Science and Technology), Shengbin Liu(Sichuan University), Xing Duan(Sichuan University), Zhenyi Niu(Sichuan University), Xiangyu Jiao(Sichuan University), Yupei Zhang(Jinan University), Xi He(Second Military Medical University), Xiaoling Yin(Sichuan University), Xing Lan(Sichuan University), Qian Zheng(Sichuan University)
Cited by 9
Related Papers
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics
|Signal Transduction and Targeted Therapy|2022|1.3k
mRNA-based therapeutics: powerful and versatile tools to combat diseases
|Signal Transduction and Targeted Therapy|2022|710
Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment
|Nature Nanotechnology|2024|148
Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
|Science Advances|2022|96
The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancer
|Critical Reviews in Oncology/Hematology|2020|71